Immunopathological Patterns of the Stomach in Adenocarcinoma of the Esophagus, Cardia, and Gastric Antrum: Gastric Profiles in Siewert Type I and II Tumors

Annals of Thoracic Surgery

Volumn 83, Issue 5, 2007, Pages 1814-1819

  Mattioli, Sandro ^a,b   Ruffato, Alberto ^a,b   Di Simone, Massimo Pierluigi ^b   Corti, Barbara ^c   D'Errico, Antonietta ^c   Lugaresi, Maria Luisa ^a,b   Mattioli, Benedetta ^a,b   D'Ovidio, Frank ^d  

^a Villa Maria Cecilia and San Pier Damiano Hospitals   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Pathology Division   (Italy)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CARDIA; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; MALE; MIDDLE AGED; PYLORIC ANTRUM; STOMACH; STOMACH NEOPLASMS;

EID: 34247246694     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.01.016     Document Type: Article

References (35)

1. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
2. Pohl H., and Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 (2005) 142-146
3. Pera M., Manterola C., Vidal O., and Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92 (2005) 151-159
4. Velanovich V., Hollingsworth J., Suresh P., and Ben-Menachem T. Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia. Dig Surg 19 (2002) 349-353
5. Goldblum J.R., Vicari J.J., Falk G.W., et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 114 (1998) 633-639
6. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). American Joint Committee on Cancer. American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual (2002), Springer, New York, NY 101-109
7. Siewert J., Faith M., Werner M., and Stein H. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232 (2000) 353-361
8. Rizk N.P., Bach P.B., Schrag D., et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 198 (2004) 42-50
9. Ito H., Clancy T.E., Osteen R.T., et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach?. J Am Coll Surg 199 (2004) 880-886
10. Gozzetti G., Mattioli S., Spangaro M., D'Errico A., Di Simone M., and Pilotti V. Terapia del cancro del cardias. Chirurgia 1 (1988) 4
11. Mattioli S., Di Simone M.P., Ferruzzi L., et al. Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. Dis Esophagus 14 (2001) 104-109
12. DeMeester S.R. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol 13 (2006) 12-30
13. Ormsby A.H., Goldblum J.R., Rice T.W., Richter J.E., and Gramlich T.L. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma. Histopathology 38 (2001) 307-311
14. Couvelard A., Cauvin J.M., Goldfain D., et al. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut 49 (2001) 761-766
15. Taniere P., Borghi-Scoazec G., Saurin J.C., et al. Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach. Am J Surg Pathol 26 (2002) 1213-1221
16. Piazuelo M.B., Haque S., Delgado A., Du J.X., Rodriguez F., and Correa P. Phenotypic differences between esophageal and gastric intestinal metaplasia. Mod Pathol 17 (2004) 62-74
17. Morales C.P., and Spechler S.J. Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers. Am J Gastroenterol 98 (2003) 759-762
18. Flucke U., Steinborn E., Dries V., et al. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach. Histopathology 43 (2003) 127-134
19. Driessen A., Nafteux P., Lerut T., et al. Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications. Mod Pathol 17 (2004) 49-55
20. Gulmann C., Counihan I., Grace A., et al. Cytokeratin 7/20 and mucin expression patterns in oesophageal, cardia and distal gastric adenocarcinomas. Histopathology 43 (2003) 453-461
21. Van Lier M.G., Bomhof F.J., Leendertse I., Flens M., Balk A.T., and Loffeld R.J. Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia. J Clin Pathol 58 (2005) 722-724
22. Ruol A., Parenti A., Zaninotto G., et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 88 (2000) 2520-2528
23. D'Errico A., Barozzi C., Fiorentino M., et al. Role and new perspectives of transforming growth factor-alpha (TGF-alpha) in adenocarcinoma of the gastro-oesophageal junction. Br J Cancer 82 (2000) 865-870
24. Dixon M.F., Genta R.M., Yardley J.H., and Correa P. Classification and grading of gastritis. The updated Sydney SystemInternational Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20 (1996) 1161-1181
25. Cassaro M., Rugge M., Gutierrez O., Leandro G., Graham D.Y., and Genta R.M. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 95 (2000) 1431-1438
26. Ormsby A.H., Goldblum J.R., Rice T.W., et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 30 (1999) 288-294
27. Dresner S.M., Lamb P.J., Bennett M.K., Hayes N., and Griffin S.M. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 129 (2001) 103-109
28. Cense H.A., Sloof G.W., Klaase J.M., et al. Lymphatic drainage routes of the gastric cardia visualized by lymphoscintigraphy. J Nucl Med 45 (2004) 247-252
29. Ichikura T., Ogawa T., Kawabata T., Chochi K., Sugasawa H., and Mochizuki H. Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial carcinoma?. World J Surg 27 (2003) 334-338
30. Sarbia M., Donner A., Franke C., and Gabbert H.E. Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry. Hum Pathol 35 (2004) 371-376
31. Glickman J.N., Ormsby A.H., Gramlich T.L., Goldblum J.R., and Odze R.D. Interinstitutional variability and effect of tissue fixative on the interpretation of a Barrett cytokeratin 7/20 immunoreactivity pattern in Barrett esophagus. Hum Pathol 36 (2005) 58-65
32. Odze R.D. Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol 100 (2005) 1853-1867
33. Dahlberg P.S., Ferrin L.F., Grindle S.M., Nelson C.M., Hoang C.D., and Jacobson B. Gene expression profiles in esophageal adenocarcinoma. Ann Thorac Surg 77 (2004) 1008-1015
34. Brabender J., Marjoram P., Salonga D., et al. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Oncogene 23 (2004) 4780-4788
35. Luthra R., Wu T.T., Luthra M.G., et al. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24 (2006) 259-267